Luminate Medical is a healthcare technology startup based in Galway, Ireland, with a mission to improve the cancer care experience for patients. The company is focused on developing innovative devices to mitigate the side effects of cancer treatments, enabling at-home care and improving overall quality of life.
Founded in 2018, Luminate Medical operates in the Biotechnology, Health Care, and Medical Devices industries. The company's flagship product, Lily, is designed to prevent chemotherapy-induced hair loss in a comfortable and portable manner, addressing a significant concern for cancer patients undergoing treatment.
Besides Lily, Luminate Medical is also working on Lilac, touted as the world's first preventative treatment for peripheral neuropathy. Furthermore, the company has a pipeline of projects aimed at enabling remote cancer care, showcasing its commitment to revolutionizing cancer treatment methodologies.
Luminate Medical has garnered significant support, having secured a $13.65M Venture Round investment on 14 May 2024. Notably, the company has received backing from Y Combinator (S21) and has achieved success in securing various grants and investments, underscoring its potential for growth and impact in the healthcare technology sector.